ArticleBMC geriatrics2026
Admission creatinine and outcomes in very elderly critically ill patients: a retrospective cohort study.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSerum creatinine at ICU admission is a central component of prognostic assessment in critically ill patients and is widely used as a marker of kidney function in clinical practice, as well as being incorporated into established prediction models. However, in very old patients, age-related muscle loss, frailty, and altered creatinine kinetics may limit its validity. With ICU admissions among nonagenarians (≥ 90 years) steadily increasing, it remains unclear whether admission creatinine retains its prognostic relevance in this population. We therefore evaluated the prognostic value of admission creatinine for short- and long-term outcomes in critically ill nonagenarians and assessed its role within the SOFA score.
methodsThis retrospective cohort study included all patients aged ≥ 90 years admitted to the ICUs of the University Medical Center Hamburg-Eppendorf between 2008-2019. Admission serum creatinine was analyzed as the primary exposure variable. Primary outcomes were in-hospital, 90-day, and 1-year mortality. Associations between admission creatinine and outcomes were analyzed using logistic and Cox regression models adjusted for relevant confounders. To evaluate the prognostic contribution of kidney function to established risk scores, we compared the predictive performance of the full SOFA score with a modified SOFA score excluding the kidney (creatinine) component.
resultsAmong 952 patients (median age 92.2 years) in-hospital, 90-day, and 1-year mortality rates were 28.5%, 42.2%, and 57.1%, respectively. Admission creatinine was not independently associated with in-hospital mortality (adjusted hazard ratio [HR] 1.07, 95% CI 0.92-1.26). In contrast, higher admission creatinine independently predicted 90-day mortality (adjusted HR 1.16, 95% CI 1.01-1.34) and 1-year mortality (adjusted HR 1.20, 95% CI 1.06-1.36). The Full and non-kidney SOFA scores performed similarly (AUC 0.79 each).
conclusionsIn critically ill patients aged ≥ 90 years, admission creatinine does not independently predict short-term outcomes but remains a robust predictor of mid- and long-term mortality. The unchanged performance of the SOFA score after removal of its kidney component underscores the limited relevance of creatinine for short-term risk stratification in this age group and supports age-adapted interpretation of kidney biomarkers and prognostic models in very old ICU patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.